Evidence map›Paper›PMID 38867533›Full record

ArticleCurrent pharmaceutical design2025

Synthesis, Characterization, and Stability Optimization of Ibuprofen Cocrystals Employing Various Hydrophilic Polymers.

Ayesha Hassan, Jamshaid Ali Khan, Fazli Nasir, Hira Shabir, Peer Abdul Hannan, Rahim Ullah, Afnan Jan, Asaad Khalid, Ajmal Khan, Ahmed Al-Harrasi

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayesha HassanDepartment of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.
Jamshaid Ali KhanDepartment of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.
Fazli NasirDepartment of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.
Hira ShabirDepartment of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.
Peer Abdul HannanDepartment of Pharmacy, Faculty of Life Sciences, Sarhad University of Science and Information Technology, Peshawar, KPK, Pakistan.
Rahim UllahDepartment of Pharmacy, Faculty of Life Sciences, Sarhad University of Science and Information Technology, Peshawar, KPK, Pakistan.
Afnan JanDepartment of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Asaad KhalidSubstance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan 45142, Saudi Arabia.
Ajmal KhanNatural and Medical Sciences Research Center, University of Nizwa, Birkat-ul- Mouz 616, Nizwa, Sultanate of Oman.
Ahmed Al-HarrasiNatural and Medical Sciences Research Center, University of Nizwa, Birkat-ul- Mouz 616, Nizwa, Sultanate of Oman.

Funding

Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia RG24-L05
6 · The paper itself

Abstract

backgroundCocrystals are an efficient way for the delivery of low soluble drugs but when dissolved they rapidly disproportionate. To formulate the cocrystals in tablets, cocrystals must be stabilized. In this study ibuprofen-nicotinamide (IBU-NIC) cocrystals were synthesized initially by slow solvent evaporation and for bulk production by fast solvent evaporation techniques.

methodsThe cocrystals were characterized by powder X-ray diffraction (PXRD), Fourier transform infrared spectrophotometer (FTIR), differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and optical microscopy. The ibuprofen cocrystals showed greater solubility compared to the parent drug.

resultsIntrinsic dissolution data was utilized for efficacious screening of tablet formulations. Using hydrophilic polymers at a ratio of 6:1 (polymer to IBU-NIC cocrystal ratio), hydroxypropyl methylcellulose (F

conclusionSignificant increase in the dissolution rate of cocrystal was observed with no phase change in all formulations.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalIbuprofenPolymersCalorimetry, Differential ScanningCrystallizationDrug LiberationDrug StabilityHydrophobic and Hydrophilic InteractionsSolubilityTabletsX-Ray DiffractionAnti-Inflammatory Agents, Non-SteroidalIbuprofenPolymersTabletsBCS class-IIbioavailabilityCocrystalformulations.ibuprofen-nicotinamidetabletability

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.